- $11.46bn
- $18.71bn
- $8.25bn
- 56
- 55
- 91
- 76
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 11.65 | ||
| PEG Ratio (f) | 0.35 | ||
| EPS Growth (f) | 50.13% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 3.87 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 14.24 | ||
| Price to Sales | 1.39 | ||
| EV to EBITDA | 11.76 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 8.81% | ||
| Return on Equity | 6.55% | ||
| Operating Margin | 12.55% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 7,281 | 8,171 | 8,130 | 8,197 | 8,254 | 8,284.34 | 8,203.57 | 3.19% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | +28.3 | -8.01 | +0.22 | -61.05 | +82.32 | +8.66 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Solventum Corp. is a global healthcare company. Its segments include Medical Surgical, Dental Solutions, Health Information Systems, and Purification and Filtration. Medical Surgical is a provider of solutions including advanced wound care, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. Dental Solutions provides dental and orthodontic products include brackets, aligners, restorative cements, and bonding agents that span the life of the tooth, including products designed for preventative dental care, direct and indirect restoration, and broad orthodontic needs. Health Information Systems offers healthcare systems with software solutions, including computer-assisted physician documentation, direct-to-bill and coding automation, speech recognition, and data visualization platforms. Purification and Filtration is a provider of purification and filtration technologies including filters, purifiers, cartridges, and membranes.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- January 24th, 2023
- Public Since
- March 26th, 2024
- No. of Shareholders
- 46,585
- No. of Employees
- 22,000
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
New York Stock Exchange- Shares in Issue
- 173,002,926
- Address
- C/O 3M Company, ST. PAUL, 55144-1000
- Web
- https://www.solventum.com/en-us/home/
- Phone
- +1 6517331110
- Auditors
- PricewaterhouseCoopers LLP
Upcoming Events for SOLV
Q1 2025 Solventum Corp Earnings Release
Q1 2025 Solventum Corp Earnings Call
Q2 2025 Solventum Corp Earnings Release
Similar to SOLV
Abbott Laboratories
New York Stock Exchange
Agilent Technologies
New York Stock Exchange
Alcon AG
New York Stock Exchange
Artivion
New York Stock Exchange
Avanos Medical
New York Stock Exchange
FAQ
What is the Solventum share price?
As of Today at 23:19 UTC, shares in Solventum are trading at $66.26. This share price information is delayed by 15 minutes.
How has the Solventum share price performed this year?
Shares in Solventum last closed at $66.26 and the price had moved by +7.3% over the past 365 days. In terms of relative price strength the Solventum share price has outperformed the S&P500 Index by +0.9% over the past year.
What are the analyst and broker recommendations for Solventum?
The overall consensus recommendation for Solventum is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Solventum dividend yield?
Solventum does not currently pay a dividend.
Does Solventum pay a dividend?
Solventum does not currently pay a dividend.
When does Solventum next pay dividends?
Solventum does not currently pay a dividend.
How do I buy Solventum shares?
To buy shares in Solventum you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Solventum?
As of the previous close price of $66.26, shares in Solventum had a market capitalisation of $11.46bn.
Where are Solventum shares listed?
Here are the trading details for Solventum:
- Country of listing: United States
- Exchange: NYQ
- Ticker Symbol: SOLV
What kind of share is Solventum?
Based on an overall assessment of its quality, value and momentum Solventum is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Solventum share price forecast for 2025?
The analyst consensus target price for shares in Solventum is $80.89. That is 22.08% above the last closing price of $66.26.
Analysts covering Solventum currently have a consensus Earnings Per Share (EPS) forecast of $5.54 for the next financial year.
Find out moreWhat is the trend in the Solventum share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Solventum. Over the past six months, its share price has underperformed the S&P500 Index by -0.35%.
As of the last closing price of $66.26, shares in Solventum were trading -2.77% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Solventum PE Ratio?
The Solventum PE ratio based on its reported earnings over the past 12 months is 11.65. The shares last closed at $66.26.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Solventum?
We do not have data on Solventum's directors